ArticleFuture oncology (London, England)2025

Pathologic complete response after neoadjuvant chemotherapy for HER-2 negative breast cancer with HRR mutation.

Xi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.